Bridgewest Ventures
Bridgewest Ventures is a venture capital and incubator firm headquartered in Auckland, New Zealand. It funds and supports early-stage companies across biotechnology, agtech, pharmaceuticals, unmanned aerial vehicles, Internet of Things, semiconductors, artificial intelligence, software development, drug discovery, life sciences, and health tech, seeking opportunities with global commercialization.
2 past transactions
TheiaNova
TheiaNova specializes in developing nonsurgical therapies for patients with vision impairment caused by ectatic vision disorders, such as keratoconus. Their therapy aims to induce therapeutic remodeling of the cornea, enabling healthcare professionals to manage vision impairments through corrective lenses or halt disease progression via corneal crosslinking.
MACSO
MACSO aims to give AI the capacity to mimic human senses in order to prevent catastrophes from occurring. Their initial application employs AI and acoustic sensors to identify respiratory sickness in animals on commercial livestock farms early.
MACSO is headquartered in Auckland, New Zealand and was founded in 2021.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.